← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2013Last known activity
Jul 9, 2024
Timeline
2010s
- Jun 1, 2013
Neumora Therapeutics, Inc.— Founded
Drugs by trial phase (4 distinct, 13 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (16)
- NCT06546995Lead sponsorPhase 1Jul 9, 2024
- NCT06429722Lead sponsorPhase 2May 13, 2024
- NCT06058013Lead sponsorPhase 3Nov 30, 2023
- NCT06058039Lead sponsorPhase 3Nov 30, 2023
- NCT06029439Lead sponsorPhase 3Nov 10, 2023
- NCT06029426Lead sponsorPhase 3Sep 20, 2023
- NCT04221230Study directorPhase 2Jan 31, 2020
- NCT04221230Lead sponsorPhase 2Jan 31, 2020
- NCT03608371Lead sponsorPhase 2Aug 31, 2018
- NCT03608371Study directorPhase 2Aug 31, 2018
- NCT03193398Study directorPhase 2Jun 12, 2017
- NCT03193398Lead sponsorPhase 2Jun 12, 2017
- NCT01798303Lead sponsorPhase 2Jul 1, 2013
- NCT01724112Lead sponsorPhase 2Nov 1, 2012
- NCT01404091Lead sponsorPhase 1Jul 1, 2011
Details
- Founded
- South San Francisco, CA, US Jun 1, 2013
- Last known activity
- Jul 9, 2024